Home / Publications / Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds

Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds

Lyubov V Vinogradova 1
Lyubov V Vinogradova
Kristina Yuryevna Komarova 1
Kristina Yuryevna Komarova
Mikhail Vasiljevich Chudinov 1
Mikhail Vasiljevich Chudinov
Elizaveta Vladimirovna Rogacheva 2
Elizaveta Vladimirovna Rogacheva
Lyudmila Aleksandrovna Kraeva 2
Lyudmila Aleksandrovna Kraeva
Alexei Yur'evich Lukin 1
Alexei Yur'evich Lukin
1 M.V. Lomonosov Institute of Fine Chemical Technologies, MIREA - Russian Technological University, Moscow, Russian Federation
2 St. Petersburg Pasteur Institute, St. Petersburg, Russian Federation
Published 2024-04-22
CommunicationVolume 34, Issue 3, 362-364
2
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Vinogradova L. V. et al. Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds // Mendeleev Communications. 2024. Vol. 34. No. 3. pp. 362-364.
GOST all authors (up to 50) Copy
Vinogradova L. V., Komarova K. Y., Chudinov M. V., Rogacheva E. V., Kraeva L. A., Lukin A. Y. Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds // Mendeleev Communications. 2024. Vol. 34. No. 3. pp. 362-364.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2024.04.016
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.04.016
TI - Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds
T2 - Mendeleev Communications
AU - Vinogradova, Lyubov V
AU - Komarova, Kristina Yuryevna
AU - Chudinov, Mikhail Vasiljevich
AU - Rogacheva, Elizaveta Vladimirovna
AU - Kraeva, Lyudmila Aleksandrovna
AU - Lukin, Alexei Yur'evich
PY - 2024
DA - 2024/04/22
PB - Mendeleev Communications
SP - 362-364
IS - 3
VL - 34
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2024_Vinogradova,
author = {Lyubov V Vinogradova and Kristina Yuryevna Komarova and Mikhail Vasiljevich Chudinov and Elizaveta Vladimirovna Rogacheva and Lyudmila Aleksandrovna Kraeva and Alexei Yur'evich Lukin},
title = {Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds},
journal = {Mendeleev Communications},
year = {2024},
volume = {34},
publisher = {Mendeleev Communications},
month = {Apr},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.04.016},
number = {3},
pages = {362--364},
doi = {10.1016/j.mencom.2024.04.016}
}
MLA
Cite this
MLA Copy
Vinogradova, Lyubov V., et al. “Scaffold hopping in the oxadiazole antibiotic structure leads to more active compounds.” Mendeleev Communications, vol. 34, no. 3, Apr. 2024, pp. 362-364. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2024.04.016.

Keywords

2
6-diazaspiro[3.4]octane.
antibiotic resistance
carboxamides
ESKAPE pathogens
isosteric replacement
methicillin-resistant bacteria
non-β-lactam antibiotics
organofluorine compounds

Abstract

Isosteric replacement of the oxadiazole ring by amide bond in the structure of new non-β-lactam antibiotics led to compounds with higher activity against Gram-positive pathogens of ESKAPE panel. A series of 17 compounds were synthesized by acylation of 4-(4-fluorophenoxy)aniline with various amino acids. The spirocyclic derivative with 6-methylsulfonyl-2,6-diazaspiro[3.4]octane moiety showed excellent minimum inhibitory concentrations of 0.093-0.75 μg ml−1 against a number of methicillin-resistant Staphylococcus aureus strains.

References

.
Discovery of a New Class of Non-β-lactam Inhibitors of Penicillin-Binding Proteins with Gram-Positive Antibacterial Activity
O’Daniel P.I., Peng Z., Pi H., Testero S.A., Ding D., Spink E., Leemans E., Boudreau M.A., Yamaguchi T., Schroeder V.A., Wolter W.R., Llarrull L.I., Song W., Lastochkin E., Kumarasiri M., et. al.
Journal of the American Chemical Society, 2014
.
Clinical relevance of the ESKAPE pathogens
Pendleton J.N., Gorman S.P., Gilmore B.F.
Expert Review of Anti-Infective Therapy, 2013
.
Structure–Activity Relationship for the Oxadiazole Class of Antibiotics
Spink E., Ding D., Peng Z., Boudreau M.A., Leemans E., Lastochkin E., Song W., Lichtenwalter K., O’Daniel P.I., Testero S.A., Pi H., Schroeder V.A., Wolter W.R., Antunes N.T., Suckow M.A., et. al.
Journal of Medicinal Chemistry, 2015
.
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective
Shalaby M.W., Dokla E.M., Serya R.A., Abouzid K.A.
European Journal of Medicinal Chemistry, 2020
.
Structure–Activity Relationship for the Oxadiazole Class of Antibacterials
Boudreau M.A., Ding D., Meisel J.E., Janardhanan J., Spink E., Peng Z., Qian Y., Yamaguchi T., Testero S.A., O’Daniel P.I., Leemans E., Lastochkin E., Song W., Schroeder V.A., Wolter W.R., et. al.
ACS Medicinal Chemistry Letters, 2019
.
Synergism of a Novel 1,2,4-oxadiazole-containing Derivative with Oxacillin against Methicillin-Resistant Staphylococcus aureus
.
Mechanistic Studies and In Vivo Efficacy of an Oxadiazole-Containing Antibiotic
Naclerio G.A., Abutaleb N.S., Onyedibe K.I., Karanja C., Eldesouky H.E., Liang H., Dieterly A., Aryal U.K., Lyle T., Seleem M.N., Sintim H.O.
Journal of Medicinal Chemistry, 2022
.
Mechanisms of Methicillin Resistance in Staphylococcus aureus
Peacock S.J., Paterson G.K.
Annual Review of Biochemistry, 2015
.
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics
Tresse C., Radigue R., Gomes Von Borowski R., Thepaut M., Hanh Le H., Demay F., Georgeault S., Dhalluin A., Trautwetter A., Ermel G., Blanco C., van de Weghe P., Jean M., Giard J., Gillet R., et. al.
Bioorganic and Medicinal Chemistry, 2019
.
A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies
Verma S.K., Verma R., Kumar K.S., Banjare L., Shaik A.B., Bhandare R.R., Rakesh K.P., Rangappa K.S.
European Journal of Medicinal Chemistry, 2021
.
5-Nitrofuran-Tagged Oxazolyl Pyrazolopiperidines: Synthesis and Activity against ESKAPE Pathogens
Rogacheva E., Kraeva L., Lukin A., Vinogradova L., Komarova K., Chudinov M., Gureev M., Chupakhin E.
Molecules, 2023
.
A Potent and Narrow-Spectrum Antibacterial against Clostridioides difficile Infection
Qian Y., Birhanu B.T., Yang J., Ding D., Janardhanan J., Mobashery S., Chang M.
Journal of Medicinal Chemistry, 2023
.
Lipophilic Imidazolylpyridines with Antimicrobial Activity
Vedekhina T.S., Dogonadze M.Z., Vinogradova T.I., Chudinov M.V., Lukin A.Y.
Pharmaceutical Chemistry Journal, 2023